(a) In unusual circumstances, the Director, PAM may authorize the use of evaluation differentials other than those prescribed in FAR 25.105 for a particular acquisition.
(b) Requests for use of other evaluation differentials shall be submitted by the HCA to the Director, PAM for further action.
source: 75 FR 19829, Apr. 15, 2010, unless otherwise noted.
cite as: 48 CFR 1425.105